CATEGORIES
Tanvex BioPharma appoints Stephen Lam as CEO
Tanvex BioPharma, Inc., Taiwan-based biosimilar-focused biopharmaceutical company and a contract development and manufacturing organisation (CDMO,) has announced that its Board of Directors has appointed Stephen Lam as the company's Chief Executive Officer (CEO).
Zuellig Pharma: A Sustainable Approach to Healthcare Access Through Innovative Solutions
The equitable distribution of medicines and their accessibility are critical to the resilience of the healthcare system.
Korea announces first joint degree programme in AI in partnership with US
Korea Advanced Institute of Science and Technology (KAIST) and New York University, US have signed a Memorandum of Understanding (MoU) to introduce a graduate programme for a joint degree in the field of artificial intelligence (AI).
TriMedSoc Alliance renews collaboration, uniting Singapore medical students
Student bodies from Singapore’s three medical schools renewed their partnership, three years after the TriMedSoc Alliance was first established.
Bharat BioEconomy to touch $30 trillion by 2050: IBER 2024
“The Indian BioEconomy is projected to rise to $30 trillion by 2050, within a global economy valued at $228 trillion, representing a significant increase in its economic share from 4 to 13 per cent,” according to the India BioEconomy Report (IBER 2024), prepared for 'Make In India Facilitation Cell for Biotechnology' of Biotechnology Industry Research Assistance Council (BIRAC), by Association of Biotechnology Led Enterprises (ABLE).
Why Cyber-resilience is Crucial
In recent years, ransomware attacks have become more regular, stealthy, and expensive. They have also been developing swiftly.
"ICMR has committed to funding all aspects of Phase I trials of Zika vaccine"
Hyderabad-based Indian Immunologicals Ltd (IIL) has signed an agreement with the Indian Council of Medical Research (ICMR) on September 12 for clinical development of India’s first codon de-optimised live attenuated Zika vaccine.
"Developing capabilities to profile the next gen compounds in new modalities is expected to drive preclinical CRO growth"
The preclinical Contract Research Organisation (CRO) sector in India is witnessing massive transformation with huge investments being made in this sector by domestic and multinational players to cater to the global needs.
"The ongoing alignment of clinical trial regulations across APAC with global standards is significant"
Celebrating 25 years of ground-breaking technological innovation across more than 34,000 trials and 10 million patients, Medidata, a Dassault Systèmes brand headquartered in New York City and having strong presence in the United Kingdom and the Asia Pacific (APAC) region offers industry-leading expertise, analyticspowered insights, and the largest patient-level historical clinical trial data set in the world.
How Asia is Addressing Mental Health Issues?
Nearly one billion people globally live with mental health conditions, and about 260 million of them reside in the World Health Organization WHO) South-East Asia Region. Governments across Asia are ramping up efforts to combat the rising mental health crisis. As October 10 will be observed as World Mental Health Day, we take a look at the region's focus on policy reforms to address the growing burden of mental healthcare across Asia.
Lessons from Singapore's Success
The Biomedical Sciences industry, which comprises the biopharmaceutical and medical technology sectors, is a key contributor to Singapore’s economy.
How Asia's Emerging As Biomanufacturing Powerhouse
Asia is poised to become a manufacturing powerhouse, building on its success in clinical trials and biotechnology innovations. While China has already established itself as a manufacturing leader, other countries in the region are following suit. With nations like Singapore, South Korea, and India recently launching ambitious policies to boost the sector, the region is gearing up for a significant transformation in its bio-manufacturing capabilities.
First cloud-based AI endoscopy system for colonoscopy gets US FDA clearance
Odin Medical, an Olympus Corporation company, has received US Food and Drug Administration (FDA) 510(k) clearance for the first cloudbased Artificial Intelligence (AI) technology designed to assist gastroenterologists in detecting suspected colorectal polyps during colonoscopy procedures, the CADDIE computer-aided detection (CADe) device.
PAHO and Alzheimer's Disease International join forces to end stigma around dementia
The Pan American Health Organization (PAHO) and Alzheimer's Disease International (ADI) have launched a new campaign, a joint initiative to raise awareness about dementia and to address the stigma that surrounds the condition in the region of the Americas.
WHO prequalifies first vaccine against mpox
The World Health Organization (WHO) has announced the MVA-BN vaccine as the first vaccine against mpox to be added to its prequalification list.
WHO launches global framework for understanding the origins of new or re-emerging pathogens
With the support of the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), the World Health Organization (WHO) has published a global framework to help Member States comprehensively investigate the origins of new and re-emerging pathogens.
Lotte Holdings unveils new healthcare and biopharmaceutical corporate venture capital
Lotte Holdings Co. has announced the establishment of a new Healthcare and Biopharmaceutical Corporate Venture Capital (CVC) dedicated to investing in biopharmaceuticals and next-generation modalities.
IIM Bangalore to have India's first Global Centre of Excellence on PE & VC
Professor U Dinesh Kumar, Dean, Faculty, at the Indian Institute of Management (IIM) Bangalore has signed a Memorandum of Understanding (MoU), with Mathew Cyriac, Executive Chairman, Florintree Advisors and alumnus of the PGP Class of 1994, to pave the way to the setting up of a global Centre of Excellence, the Tony James Centre for Private Equity (PE) and Venture Capital (VC), at IIM Bangalore.
Respiree teams up with Roche Diagnostics to improve patient monitoring in APAC
Existing patient monitoring workflows often rely on nurses managing patients from centralised workstations, monitoring vitals and biomarkers at different intervals, and manually collecting vitals.
See-Mode Technologies gets US FDA clearance for thyroid ultrasound AI analysis software
Australia-based startup See-Mode Technologies, a global innovator in artificial intelligence (AI) for ultrasound imaging, has announced the receipt of 510(k) clearance from the US Food and Drug Administration (FDA) for their thyroid ultrasound analysis and reporting software.
Bharat Biotech to collaborate with Alopexx for development of broad-spectrum antimicrobial vaccine
Indian biopharma firm Bharat Biotech has announced a collaboration with US-based Alopexx, Inc., for the co-development and commercialisation of Alopexx’s proprietary broad-spectrum antimicrobial vaccine, AV0328, in India and other low income and lower middleincome countries.
Olympus extends advanced bipolar surgical energy portfolio
Japan-based Olympus Corporation, a global medical technology company, has announced the launch of two new jaw designs in the POWERSEAL Sealer/ Divider family of advanced bipolar surgical energy products- the POWERSEAL Straight Jaw, Double-action (SJDA) and the POWERSEAL Curved Jaw, Single-action (CJSA).
GSK launches Herpes Zoster vaccine 'Shingrix' in Malaysia
GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) has announced the launch of its Herpes Zoster vaccine, Shingrix, also known as Recombinant Zoster Vaccine, Adjuvanted (RZV) in Malaysia for the prevention of shingles (herpes zoster, HZ) and post-herpetic neuralgia (PHN) in adults aged 50 years and over.
Bora Pharma makes investment into Tanvex for global biomanufacturing services
Taiwan-based Bora Pharmaceuticals Co. has announced that its Board of Directors has approved a strategic investment into Tanvex Biopharma Co., whereby Bora Biologics, a wholly owned subsidiary of Bora and specialist large molecule Contract Development and Manufacturing Organisation (CDMO), and Tanvex will combine their biomanufacturing facilities to create a global solution for biologics development and supply.
Takeda offers over $32 M for five new global CSR partnerships
Japanese pharma firm Takeda has awarded JPY 4.6 billion (approximately $32 million) to five new partners in the field of global corporate social responsibility (CSR).
Neovantage Innovation Parks secures Rs 300 Cr for life sciences real estate portfolio in India
Neovantage Innovation Parks, South Asia’s largest private owner and operator of life sciencesfocused real estate, has secured its inaugural green loan of Rs 300 crore from HSBC India.
CSL sells plasma collection and fractionation operations in China for $185 M
Australia-based biotechnology company CSL Limited has entered into an agreement with Chengdu Rongsheng Pharmaceutical to sell its Wuhan Zhong Yuan Rui De Biologicals Products (Ruide) plasma collection and fractionation operations for cash proceeds of $185 million.
UCB to divest mature neurology and allergy business in China for $680 M
UCB, a global biopharmaceutical company based in Belgium, has announced a strategic divestment deal in China, underscoring its strategic shift towards innovation and partnership in one of the world’s fastestgrowing pharmaceutical markets.
New Zealand to update clinical trial regulatory guidelines
Medsafe, the New Zealand Medicines and Medical Devices Safety Authority, is seeking public feedback on a series of proposed updates to the regulatory guidelines for people conducting clinical trials for medicines and medical devices.
UAE to create national scientific guide to tackle obesity and weight management
The Ministry of Health and Prevention (MoHAP), in the United Arab Emirates (UAE), has teamed up with Novo Nordisk Pharma Gulf, a major player in global healthcare, to create a national scientific guide to tackle obesity and manage weight.